899 related articles for article (PubMed ID: 14983235)
61. Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells.
Imai M; Kaczmarek E; Koziak K; Sévigny J; Goepfert C; Guckelberger O; Csizmadia E; Schulte Am Esch J; Robson SC
Biochemistry; 1999 Oct; 38(41):13473-9. PubMed ID: 10521254
[TBL] [Abstract][Full Text] [Related]
62. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury.
Pompermayer K; Amaral FA; Fagundes CT; Vieira AT; Cunha FQ; Teixeira MM; Souza DG
Eur J Pharmacol; 2007 Feb; 556(1-3):215-22. PubMed ID: 17182029
[TBL] [Abstract][Full Text] [Related]
63. Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin.
Ishikawa M; Stokes KY; Zhang JH; Nanda A; Granger DN
Circ Res; 2004 Feb; 94(2):239-44. PubMed ID: 14670846
[TBL] [Abstract][Full Text] [Related]
64. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury.
Vajdová K; Heinrich S; Tian Y; Graf R; Clavien PA
Liver Transpl; 2004 Apr; 10(4):520-8. PubMed ID: 15048795
[TBL] [Abstract][Full Text] [Related]
65. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
66. The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells.
Yegutkin GG; Henttinen T; Samburski SS; Spychala J; Jalkanen S
Biochem J; 2002 Oct; 367(Pt 1):121-8. PubMed ID: 12099890
[TBL] [Abstract][Full Text] [Related]
67. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
[TBL] [Abstract][Full Text] [Related]
68. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
[TBL] [Abstract][Full Text] [Related]
69. Apyrase treatment prevents ischemia-reperfusion injury in rat lung isografts.
Sugimoto S; Lin X; Lai J; Okazaki M; Das NA; Li W; Krupnick AS; Chen R; Jeong SS; Patterson GA; Kreisel D; Gelman AE
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):752-9. PubMed ID: 19698866
[TBL] [Abstract][Full Text] [Related]
70. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning.
Matsumoto T; O'Malley K; Efron PA; Burger C; McAuliffe PF; Scumpia PO; Uchida T; Tschoeke SK; Fujita S; Moldawer LL; Hemming AW; Foley DP
Surgery; 2006 Nov; 140(5):793-802. PubMed ID: 17084723
[TBL] [Abstract][Full Text] [Related]
71. Toll-like receptor 4 mediates lung ischemia-reperfusion injury.
Shimamoto A; Pohlman TH; Shomura S; Tarukawa T; Takao M; Shimpo H
Ann Thorac Surg; 2006 Dec; 82(6):2017-23. PubMed ID: 17126102
[TBL] [Abstract][Full Text] [Related]
72. Effect of high glucose levels in human platelet NTPDase and 5'-nucleotidase activities.
Lunkes GI; Lunkes DS; Leal D; Araújo Mdo C; Corrêa M; Becker L; Rosa CS; Morsch VM; Schetinger MR
Diabetes Res Clin Pract; 2008 Sep; 81(3):351-7. PubMed ID: 18644642
[TBL] [Abstract][Full Text] [Related]
73. Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis.
Zimmermann H
Nat Med; 1999 Sep; 5(9):987-8. PubMed ID: 10470068
[No Abstract] [Full Text] [Related]
74. Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia.
Sun X; Imai M; Nowak-Machen M; Guckelberger O; Enjyoji K; Wu Y; Khalpey Z; Berberat P; Munasinghe J; Robson SC
Purinergic Signal; 2011 Dec; 7(4):427-34. PubMed ID: 21656186
[TBL] [Abstract][Full Text] [Related]
75. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role?
Salcido-Ochoa F; Tsang J; Tam P; Falk K; Rotzschke O
Transplant Rev (Orlando); 2010 Apr; 24(2):52-66. PubMed ID: 20153159
[TBL] [Abstract][Full Text] [Related]
76. The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease.
El-Omar MM; Islam N; Broekman MJ; Drosopoulos JH; Roa DC; Lorin JD; Sedlis SP; Olson KE; Pulte ED; Marcus AJ
Thromb Res; 2005; 116(3):199-206. PubMed ID: 15935828
[TBL] [Abstract][Full Text] [Related]
77. In vivo evaluation of platelet--endothelial interactions after transient retinal ischemia.
Nishijima K; Kiryu J; Tsujikawa A; Honjo M; Nonaka A; Yamashiro K; Tanihara H; Tojo SJ; Ogura Y; Honda Y
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2102-9. PubMed ID: 11481278
[TBL] [Abstract][Full Text] [Related]
78. Perfluorocarbon in microcirculation during ischemia reperfusion.
Cabrales P; Tsai AG; Intaglietta M
J Am Coll Surg; 2007 Feb; 204(2):225-35. PubMed ID: 17254926
[TBL] [Abstract][Full Text] [Related]
79. Impaired ATP-induced coronary blood flow and diminished aortic NTPDase activity precede lesion formation in apolipoprotein E-deficient mice.
Mercier N; Kiviniemi TO; Saraste A; Miiluniemi M; Silvola J; Jalkanen S; Yegutkin GG
Am J Pathol; 2012 Jan; 180(1):419-28. PubMed ID: 22074736
[TBL] [Abstract][Full Text] [Related]
80. Soluble apyrases release adp during ATP hydrolysis.
Chen W; Guidotti G
Biochem Biophys Res Commun; 2001 Mar; 282(1):90-5. PubMed ID: 11263976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
